ARROWHEAD PHARMACEUTICALS, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Myszkowski Kenneth Allen | Chief Financial Officer | Sale | 27,071 | $22.00 | $595,562 | 278,536 | May 21, 2019 |
| Anzalone Christopher Richard | Chief Executive Officer | Sale | 50,000 | $19.30 | $965,000 | 2,092,455 | Apr 3, 2019 |
| GIVEN BRUCE D | Chief Operating Officer | Option Exercise | 42,500 | $2.01 | $85,425 | 687,106 | Mar 1, 2019 |
| GIVEN DOUGLAS B | — | Option Exercise | 10,000 | $2.62 | $26,200 | 233,130 | Feb 26, 2019 |
| GIVEN BRUCE D | Chief Operating Officer | Option Exercise | 42,500 | $2.01 | $85,425 | 687,106 | Feb 25, 2019 |
| Myszkowski Kenneth Allen | Chief Financial Officer | Option Exercise | 8,000 | $5.20 | $41,600 | 313,607 | Feb 19, 2019 |
| GIVEN BRUCE D | Chief Operating Officer | Option Exercise | 42,500 | $2.01 | $85,425 | 687,106 | Feb 15, 2019 |
| GIVEN BRUCE D | Chief Operating Officer | Sale | 42,500 | $17.06 | $725,050 | 670,856 | Feb 8, 2019 |
| GIVEN BRUCE D | Chief Operating Officer | Sale | 22,500 | $14.48 | $325,800 | 847,856 | Feb 5, 2019 |
| GIVEN BRUCE D | Chief Operating Officer | Sale | 28,500 | $13.85 | $394,725 | 870,356 | Feb 1, 2019 |
| GIVEN BRUCE D | Chief Operating Officer | Sale | 17,500 | $13.15 | $230,125 | 898,856 | Jan 22, 2019 |
| GIVEN DOUGLAS B | — | Sale | 3,000 | $13.58 | $40,740 | 178,130 | Jan 22, 2019 |
| O'Brien Patrick | General Counsel | Sale | 72,000 | $14.43 | $1,038,960 | 233,000 | Jan 18, 2019 |
| Myszkowski Kenneth Allen | Chief Financial Officer | Sale | 81,875 | $14.55 | $1,191,281 | 305,607 | Jan 17, 2019 |
| Li Zhen | Snr. VP, Chem and Non-Clin Dev | Sale | 40,500 | $14.34 | $580,770 | 201,700 | Jan 14, 2019 |
| GIVEN BRUCE D | Chief Operating Officer | Sale | 42,666 | $14.40 | $614,390 | 1,068,356 | Jan 14, 2019 |
| Waddill William D. | — | Sale | 8,500 | $14.77 | $125,545 | 46,500 | Jan 11, 2019 |
| Ferrari Mauro | — | Award / Grant | 3,429 | — | — | 19,656 | Jan 2, 2019 |
| Myszkowski Kenneth Allen | Chief Financial Officer | Award / Grant | 85,000 | — | — | 395,815 | Jan 2, 2019 |
| Waddill William D. | — | Award / Grant | 30,000 | — | — | 55,000 | Jan 1, 2019 |
| PERRY MICHAEL S | — | Award / Grant | 36,000 | — | — | 221,000 | Jan 1, 2019 |
| GIVEN DOUGLAS B | — | Award / Grant | 36,000 | — | — | 181,130 | Jan 1, 2019 |
| Li Zhen | Snr. VP, Chem and Non-Clin Dev | Award / Grant | 75,000 | — | — | 242,200 | Jan 1, 2019 |
| O'Brien Patrick | General Counsel | Award / Grant | 70,000 | — | — | 305,000 | Jan 1, 2019 |
| GIVEN BRUCE D | Chief Operating Officer | Sale | 20,000 | $11.98 | $239,600 | 1,098,356 | Jan 1, 2019 |
| Anzalone Christopher Richard | Chief Executive Officer | Award / Grant | 600,000 | — | — | 2,142,455 | Jan 1, 2019 |
| GIVEN DOUGLAS B | — | Sale | 3,000 | $12.00 | $36,000 | 145,130 | Dec 27, 2018 |
| Anzalone Christopher Richard | Chief Executive Officer | Sale | 90,000 | $13.92 | $1,252,800 | 1,542,455 | Dec 19, 2018 |
| Ferrari Mauro | — | Award / Grant | 3,459 | — | — | 16,227 | Dec 18, 2018 |
| Anzalone Christopher Richard | Chief Executive Officer | Sale | 90,000 | $14.07 | $1,266,300 | 1,632,455 | Dec 12, 2018 |
| GIVEN DOUGLAS B | — | Sale | 3,000 | $12.74 | $38,220 | 148,130 | Nov 23, 2018 |
| Anzalone Christopher Richard | Chief Executive Officer | Sale | 76,200 | $14.35 | $1,093,470 | 1,727,755 | Nov 9, 2018 |
| GIVEN DOUGLAS B | — | Gift | 3,870 | — | — | 151,130 | Oct 22, 2018 |
| Leone Peter Brian | VP, Strategic Bus. Initiatives | Option Exercise | 34,375 | $6.15 | $211,406 | 194,375 | Oct 19, 2018 |
| Myszkowski Kenneth Allen | Chief Financial Officer | Option Exercise | 20,000 | $4.75 | $95,000 | 355,815 | Sep 6, 2018 |
| Anzalone Christopher Richard | Chief Executive Officer | Sale | 100,000 | $14.45 | $1,445,000 | 1,868,789 | Sep 4, 2018 |
| Myszkowski Kenneth Allen | Chief Financial Officer | Sale | 20,000 | $14.01 | $280,200 | 310,815 | Jun 19, 2018 |
| Myszkowski Kenneth Allen | Chief Financial Officer | Sale | 12,600 | $11.00 | $138,600 | 310,815 | May 30, 2018 |
| GIVEN DOUGLAS B | — | Sale | 25,000 | $6.63 | $165,750 | 155,000 | Apr 24, 2018 |
| Myszkowski Kenneth Allen | Chief Financial Officer | Sale | 20,000 | $8.00 | $160,000 | 310,815 | Mar 27, 2018 |
| Anzalone Christopher Richard | Chief Executive Officer | Sale | 26,000 | $7.40 | $192,400 | 1,968,789 | Mar 16, 2018 |
| Anzalone Christopher Richard | Chief Executive Officer | Sale | 100,000 | $7.41 | $741,000 | 1,994,789 | Mar 13, 2018 |
| GIVEN BRUCE D | Chief Operating Officer | Sale | 20,000 | $6.73 | $134,600 | 908,356 | Mar 5, 2018 |
| Myszkowski Kenneth Allen | Chief Financial Officer | Tax Withholding | 8,208 | $6.66 | $54,665 | 310,815 | Mar 5, 2018 |
| FRYKMAN EDWARD W | — | Award / Grant | 25,000 | — | — | 148,852 | Jan 1, 2018 |
| Waddill William D. | — | Award / Grant | 25,000 | — | — | 25,000 | Jan 1, 2018 |
| PERRY MICHAEL S | — | Award / Grant | 30,000 | — | — | 185,000 | Jan 1, 2018 |
| GIVEN DOUGLAS B | — | Award / Grant | 30,000 | — | — | 180,000 | Jan 1, 2018 |
| Leone Peter Brian | VP, Strategic Bus. Initiatives | Award / Grant | 40,000 | — | — | 130,000 | Jan 1, 2018 |
| O'Brien Patrick | General Counsel | Award / Grant | 60,000 | — | — | 235,000 | Jan 1, 2018 |